Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Iva Parvova"'
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-17 (2024)
In recent years, incretin mimetics have become an important part of type 2 diabetes mellitus therapy. The aim of this study is to evaluate the efficacy and safety of glucagon-like peptide-1 (GLP-1) receptor agonists. We performed a literature search
Externí odkaz:
https://doaj.org/article/94ba7feefc684deaa24086dad3bbb640
Autor:
Carmen Cannavale, Assunta De Rosa, Emanuil Yordanov, Iva Parvova, Emil Hristov, Valentina Petkova
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-8 (2024)
Pricing and reimbursement in the European Union (EU) are unified by Directive 89/105/EEC/21.12.1988. The directive has a framework nature; it defines deadlines for decision-making, legal protection, publicity of information, tacit consent, etc. The s
Externí odkaz:
https://doaj.org/article/4c25377c976a44638ac7463d2f7eb8e0
Autor:
Iva Parvova, Tzvetomir Delyiski, Parvoleta Peteva, Lubomir Marinchev, Emil Hristov, Emanuil Yordanov, Valentina Petkova
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-9 (2024)
Systemic vasculitides are rare and heterogeneous diseases affecting different organs and systems with varying degrees of severity depending on the type of vessels affected. The etiology and pathogenesis are unclear. Immunе mechanisms play a role in
Externí odkaz:
https://doaj.org/article/fcfed6145db9474b815cf8f226ccb443
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-6 (2024)
Depressive disorders are among the most important psychiatric problems. In everyday clinical practice, their symptoms and, respectively, their response to pharmacological treatment are both evaluated and measured subjectively. In the present paper, w
Externí odkaz:
https://doaj.org/article/08fa8d3ab47b410f807f7a307b95bbca
Autor:
Iva Parvova, Tzvetomir Delyiski, Parvoleta Peteva, Valentina Petkova, Еmil Hristov, Emanuil Yordanov, Lubomir Marinchev, Emil Milushev, Milen Dimitrov
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-9 (2024)
Working with patients with Anti-neutrophil cytoplasmic antibody (ANCA)- associated vasculitis (AAV) requires a clear understanding of their current health status. In the scientific literature, there is not enough data on their quality of life with th
Externí odkaz:
https://doaj.org/article/45f73118a2764274b33f4b9de51c2b94
Publikováno v:
Pharmacia, Vol 71, Iss , Pp 1-8 (2024)
We analyzed whether commonly used biological medicinal products and/or tyrosine kinase inhibitors with indications for treatment of rheumatologic diseases can be used in patients with concurrent COVID-19 by systematically reviewing scientific article
Externí odkaz:
https://doaj.org/article/775bd2abe7e147319e8190c7582ef130
Autor:
Russka Shumnalieva, Plamena Ermencheva, Georgi Kotov, Iva Parvova-Hristova, Konstantina Bakopoulou, Issa El Kaouri, Niya Mileva, Tsvetelina Velikova
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2264 (2024)
Systemic necrotising vasculitides (SNVs) pose significant challenges due to their diverse clinical manifestations and variable outcomes. Therefore, identifying reliable biomarkers holds promise for improving precision medicine in SNVs. This review ex
Externí odkaz:
https://doaj.org/article/37c3371e81844c279b0407fe565bdf90
Publikováno v:
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 18:145-153
Aim: The objective is to study the availability and affordability of biosimilar medicinal products containing monoclonal antibodies, measure their drug utilization, and evaluate the rational drug use globally through analysis and systematic review of
Autor:
Nikolay Nachev, Stefka Stoyanova, Antoan Rangelov, Emanuil Yordanov, Emil I Hristov, Iva Parvova, Valentina Petkova
Publikováno v:
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 18:88-98
Aim: To analyze drug utilization and rational drug use in treatment of essential arterial hypertension in Bulgaria by using quantitative and qualitative parameters at national level. To assess generic penetration as a part of rational drug use. Mater
Autor:
Stefka Stoyanova, Emanuil Yordanov, Valentina Petkova, Hristo Tzachev, E. Hristov, Iva Parvova
Publikováno v:
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 18:42-50
The entry of the biological medicinal products (BMPs) in the clinical practice more than 10 years ago raised complex regulatory issues as well as significant pharmacoeconomic concerns, because the costs of treatment is higher than the costs of the co